Research Conferences & Events

Every year the Stephenson Cancer Center (SCC) organizes and hosts research conferences and other events in order to foster an environment of scientific inquiry, exchange of ideas, and collaboration among SCC members and other investigators. These events include:

Annual and Ongoing

Oklahoma Gero-Oncology Symposium: Sarcopenia in Aging and Cancer Cachexia
At the Oklahoma Gero-Oncology Symposium, attendees will learn about the developments and progress happening in geriatric oncology from leading experts across the country. This symposium will feature a roundtable discussion with speakers from NCI and NIA, as well as a poster session.

Annual Cancer Research Symposium
Since 2011, SCC has hosted an Annual Cancer Research Symposium to provide a forum for cancer-focused researchers from a variety of disciplines to present and share their research.

The one-day conference covers three different program areas including cancer biology, cancer prevention and control and cancer therapeutics, with a trainee poster presentation competition for each of the program areas preceding the conference start. The symposium hosts more than 250 participants annually. The target audience is faculty, staff, graduate students, postdoctoral trainees, and research members.

International Ovarian Cancer Consortium Conference
The International Ovarian Cancer Consortium was organized by SCC member Dr. Danny Dhanasekaran, in collaboration with intra and extramural colleagues, as an international forum of experts who can contribute to the state-of-the-science in ovarian cancer and tumor microenvironment research. This group of national and international experts now meets annually at the SCC to present research and exchange ideas.
2019 Conference Agenda

END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer
The goal of the END2CANCER conference is to bridge laboratory research conducted in the areas of nanotechnology and drug delivery to clinical applications for the detection, diagnosis, imaging and treatment of cancer. The conference features keynote, plenary and invited lectures by eminent scientists who discuss new and emerging concepts, technologies, and challenges in translating nanomedicine from bench to bedside. The inaugural conference was held December of 2017 and was organized by Dr. Rajagopal Ramesh, Co-Leader of the SCC’s Cancer Biology Program.